Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients

Published on Nov 1, 2018in Oral Oncology3.979
· DOI :10.1016/J.ORALONCOLOGY.2018.10.006
Ester Orlandi22
Estimated H-index: 22
,
Nicola Alessandro Iacovelli10
Estimated H-index: 10
+ 8 AuthorsA. Cavallo7
Estimated H-index: 7
Sources
Abstract
Abstract Introduction/objective Oral and oropharyngeal mucositis (OM) represents a multifactorial and complex interplay of patient-, tumor-, and treatment-related factors. We aimed to build a predictive model for acute OM for locally advanced nasopharyngeal carcinoma (NPC) patients by combining clinical and dosimetric factors. Materials/methods A series of consecutive NPC patients treated curatively with IMRT/VMAT + chemotherapy at 70 Gy (2–2.12 Gy/fr) was considered. For each patient, clinical- tumor- and treatment-related data were retrospectively collected. oral cavity (OC) and parotid glands (PG, considered as a single organ) were selected as organs-at-risk (OARs). Acute OM was assessed according to CTCAE v4.0 at baseline and weekly during RT. Two endpoints were considered: grade ≥3 and mean grade ≥1.5. DVHs were reduced to Equivalent Uniform Dose (EUD). Dosimetric and clinical/treatment features selected via LASSO were inserted into a multivariable logistic model. Goodness of fit was evaluated through Hosmer-Lemeshow test and calibration plot. Results Data were collected for 132 patients. G ≥ 3 and mean G ≥ 1.5 OM were reported in 40 patients (30%). Analyses resulted in a 3-variables model for G ≥ 3 OM, including OC EUD with n = 0.05 (OR = 1.02), PG EUD with n = 1 (OR = 1.06), BMI ≥ 30 (OR = 3.8, for obese patients), and a single variable model for mean G ≥ 1.5 OM, i.e. OC EUD with n = 1 (mean dose) (OR = 1.07). Calibration was good in both cases. Conclusion OC mean dose was found to impact most on OM duration (mean G ≥ 1.5), while G ≥ 3 OM was associated to a synergic effect between PG mean dose and high dose received by small OC volumes, with BMI acting as a dose-modifying factor.
📖 Papers frequently viewed together
79 Citations
References47
Newest
#1Jin Hou (Southern Medical University)H-Index: 1
#2Hui-Min Zheng (Southern Medical University)H-Index: 8
Last. Xiao-Jun Yang (Southern Medical University)H-Index: 2
view all 6 authors...
Abstract Background and purpose Oral mucositis remains one of the most common complications of radiation therapy for patients with head and neck cancer. This study aimed to investigate the dynamic shifts in the oral mucosal microbiota and their association with the progression and aggravation of mucositis in patients with nasopharyngeal carcinoma (NPC) undergoing radiotherapy. Materials and methods In this study, oropharyngeal mucosa of patients were examined regularly, and sampled longitudinall...
23 CitationsSource
#1Andrew Macann (Auckland City Hospital)H-Index: 10
#2Fariza Fauzi (UKM: National University of Malaysia)H-Index: 7
Last. Andrea Raith (University of Auckland)H-Index: 13
view all 8 authors...
Abstract Purpose/Objective(s) To model in a subset of patients from TROG 07.03 managed at a single site the association between domiciliary based humidification use and mucositis symptom burden during radiotherapy (RT) for head and neck cancer (HNC) when factoring in volumetric radiotherapy parameters derived from tumour and normal tissue regions of interest. Materials/Methods From June 2008 through June 2011, 210 patients with HNC receiving RT were randomised to either a control arm or humidifi...
3 CitationsSource
#1Kaixin Li (Fujian Medical University)H-Index: 2
#2Ling YangH-Index: 3
Last. Ming ChenH-Index: 1
view all 7 authors...
Abstract Purpose To prospectively identify the predictive value of different dosimetric parameters and also assess the predictors of acute radiation oral mucositis (ROM). Methods In accordance with the RTOG scoring criteria, ninety-two patients with locally advanced nasopharyngeal carcinoma (NPC) treated with concurrent chemoradiotherapy were evaluated for acute ROM which was defined as severe when the score ≥3. Patients’ medical records and dosimetric data exported from IMRT plan enable the aut...
7 CitationsSource
Background There is no widely accepted intervention in the prevention of acute mucositis during chemoradiotherapy for head and neck carcinoma. In the present double-blind study, we tested 4 natural agents, propolis, aloe vera, calendula, and chamomile versus placebo. Methods Patients undergoing concomitant chemo-intensity-modulated radiotherapy (IMRT) were given natural agent or matched placebo; grade 3 mucositis on physical examination according to Common Terminology Criteria for Adverse Events...
11 CitationsSource
#1Osama Muhammad Maria (McGill University)H-Index: 6
#2Nicoletta Eliopoulos (McGill University)H-Index: 27
Last. Thierry MuanzaH-Index: 17
view all 3 authors...
Radiation-induced oral mucositis (RIOM) is a major dose-limiting toxicity in Head and Neck cancer patients. It is a normal tissue injury caused by radiation/radiotherapy (RT), which has marked adverse effects on patient quality of life and cancer therapy continuity. It is a challenge for radiation oncologists since it leads to change in dose fractionation, cancer therapy interruption, and poor local tumor control. RIOM occurs in 100% of altered fractionation radiotherapy Head and Neck cancer pat...
99 CitationsSource
#1Cheng Xu (SYSU: Sun Yat-sen University)H-Index: 11
#2Li He Zhang (SYSU: Sun Yat-sen University)H-Index: 1
Last. Jun MaH-Index: 16
view all 8 authors...
Background: To explore the value of chemoradiotherapy (CRT) in stage II nasopharyngeal carcinoma (NPC) compared to radiotherapy (RT) alone which includes two-dimensional radiotherapy (2D-RT) and intensity-modulated radiotherapy (IMRT). Methods:All topic-related comparative articles were identified by a comprehensive search of public databases (MEDLINE, EMBASE, Cochrane Library and CBMdisc). The primary outcomes were overall survival (OS), loco-regional relapse-free survival (LRRFS) and distant m...
36 CitationsSource
Purpose We assessed the presence of salivary cytokines, their modulation during chemoradiation therapy (CTRT), and their association with oral mucositis severity in patients with head and neck cancer (HNC). Methods and Materials The present prospective observational study enrolled 55 patients with locally advanced HNC requiring CTRT. We also studied 10 healthy volunteers and 10 patients with other cancers. The salivary levels of 13 cytokines were analyzed. We constructed a cytokine predictive sc...
20 CitationsSource
#1Mario J.A. Saad (State University of Campinas)H-Index: 75
#2Andrey Santos (State University of Campinas)H-Index: 10
Last. Patrícia O. Prada (State University of Campinas)H-Index: 30
view all 3 authors...
Obesity and insulin resistance are the major predisposing factors to comorbidities, such as Type 2 diabetes, nonalcoholic fatty liver disease, cardiovascular and neurodegenerative diseases, and several types of cancer. The prevalence of obesity is still increasing worldwide and now affects a large number of individuals. Here, we review the role of the gut microbiota in the pathophysiology of insulin resistance/obesity. The human intestine is colonized by ∼100 trillion bacteria, which constitute ...
186 CitationsSource
#1Gita Thanarajasingam (Mayo Clinic)H-Index: 12
#2Pamela J. Atherton (Mayo Clinic)H-Index: 38
Last. Axel Grothey (Mayo Clinic)H-Index: 86
view all 6 authors...
Summary Background Traditional methods of reporting adverse events in clinical trials are inadequate for modern cancer treatments with chronic administration. Conventional analysis and display of maximum grade adverse events do not capture toxicity profiles that evolve over time or longer lasting, lower grade toxic effects; we aimed to address this shortcoming in this study. Methods We developed an analytic approach and standardised, comprehensive format, the Toxicity over Time (ToxT) approach, ...
60 CitationsSource
Background The purpose of this study was to assess predictors of mucositis in oropharyngeal and oral cavity cancer after definitive or adjuvant volumetric modulated arc radiotherapy (VMAT) +/− chemotherapy. Methods Fifty patients were evaluated. Statistical analysis was performed for the following parameters as potential predictors of mucositis ≥ G2: total oral mucosa and oral mucosa minus target high-low radiation dose regions (planning target volumes [PTVs]), mean dose (Dmean), maximum dose (D...
16 CitationsSource
Cited By10
Newest
#1Sarah HamiltonH-Index: 10
#2Eric TranH-Index: 8
Last. Robert Olson (UNBC: University of Northern British Columbia)H-Index: 1
view all 10 authors...
Head and neck (H&N) cancer patients experience significant acute side effects from treatment. This study evaluates prospectively collected patient-reported outcomes (PROs) in H&N patients undergoing radiotherapy (RT) to assess feasibility of electronically collecting PROs and to objectively document symptom acuity and trajectory during RT. H&N patients undergoing radical RT at our multicentre institution completed a 12-item partial survey of the Vanderbilt Head & Neck Symptom Survey 2.0 prior to...
1 CitationsSource
#1Ourania Nicolatou-Galitis (UoA: National and Kapodistrian University of Athens)H-Index: 22
#2Paolo Bossi (University of Brescia)H-Index: 39
Last. René-Jean BensadounH-Index: 28
view all 4 authors...
PURPOSE To discuss the role of benzydamine in the prevention and treatment of radiation-induced oral mucositis (OM) in head and neck (H&N) cancer patients. This document represents an expert opinion paper on indications and key-role aspects in OM pathogenesis, prevention and treatment. ORAL MUCOSITIS OM represents a common side effect of chemotherapy (CHT) and radiotherapy (RT). It consists in a painful erythema involving the oral cavity mucosa, which may progress to ulceration. Five biologicall...
Source
Last. Ronghui Zheng (Guangzhou Medical University)H-Index: 5
view all 7 authors...
Objective: To investigate the clinical value of induction chemotherapy (IC) with docetaxel plus cisplatin (TP) followed by concurrent chemoradiotherapy (CCRT) with TP in locoregionally advanced nasopharyngeal carcinoma (NPC). Methods: A total of 544 patients with locoregionally advanced NPC that was newly diagnosed from January 2009 to December 2015 were included in this study. Among these patients, 251 were treated with TP induction chemotherapy followed by CCRT with cisplatin (DDP) alone (TP +...
Source
#1Hannah R. Wardill (University of Adelaide)H-Index: 16
#2Stephen T. Sonis (Brigham and Women's Hospital)H-Index: 81
Last. Joanne M. Bowen (University of Adelaide)H-Index: 49
view all 12 authors...
PURPOSE Despite advances in personalizing the efficacy of cancer therapy, our ability to identify patients at risk of severe treatment side effects and provide individualized supportive care is limited. This is particularly the case for mucositis (oral and gastrointestinal), with no comprehensive risk evaluation strategies to identify high-risk patients. We, the Multinational Association for Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) Mucositis Study Group, the...
1 CitationsSource
#1Qi-Yong Ai (CUHK: The Chinese University of Hong Kong)H-Index: 9
#2Ann D. King (CUHK: The Chinese University of Hong Kong)H-Index: 61
Last. K.C.A. Chan (CUHK: The Chinese University of Hong Kong)H-Index: 3
view all 8 authors...
AIM To evaluate whether there is an association between persistently positive plasma Epstein-Barr virus (EBV) DNA and the presence and the change in benign hyperplasia. MATERIALS AND METHODS One hundred and seventeen participants with positive-plasma EBV-DNA, but without NPC from previous nasopharyngeal carcinoma (NPC) screening, underwent follow-up magnetic resonance imaging (MRI) and plasma EBV-DNA after 2 years. Logistic regression was used to analyse associations between MRI (benign hyperpla...
Source
ObjectiveTo examine the effects of antibiotic administration on radiation-induced oral and oropharyngeal mucositis, and on the prognosis of patients with nasopharyngeal carcinoma (NPC).MethodsWe re...
Source
#1Mi Du (University of Adelaide)H-Index: 8
#2Dandara G Haag (University of Adelaide)H-Index: 7
Last. Murthy N. Mittinty (University of Adelaide)H-Index: 19
view all 5 authors...
Recent efforts to improve the reliability and efficiency of scientific research have caught the attention of researchers conducting prediction modeling studies (PMSs). Use of prediction models in o...
4 CitationsSource
#1Francesco DionisiH-Index: 7
#1F. DionisiH-Index: 1
Last. Ester OrlandiH-Index: 22
view all 13 authors...
Abstract Re-irradiation is becoming an established treatment option for recurrent or second primary head and neck cancer(HNC). However, acute and long-term RT-related toxicities could dramatically impact patients' quality of life. Due to the sparse literature regarding HNC re-irradiation, data on tolerance doses for various organs at risk (OARs) are scarce. Our aim was to systematically review the clinical literature regarding HNC re-irradiation, focusing on treatment toxicity, OARs tolerance, a...
15 CitationsSource
#1Ester OrlandiH-Index: 22
Last. Francesca De Felice (Sapienza University of Rome)H-Index: 21
view all 8 authors...
Abstract In the last decade, human microbiome research is rapidly growing involving several fields of clinical medicine and population health. Although the microbiome seems to be linked to all sorts of diseases, cancer has the biggest potential to be investigated. Following the publication of the National Institute of Health - Human Microbiome Project (NIH-HMP), the link between Head and Neck Cancer (HNC) and microbiome seems to be a fast-moving field in research area. However, robust evidence-b...
11 CitationsSource
#1John T. Lafin (UTSW: University of Texas Southwestern Medical Center)H-Index: 6
#2Ehab H. Sarsour (UI: University of Iowa)H-Index: 17
Last. Prabhat C. Goswami (UI: University of Iowa)H-Index: 34
view all 6 authors...
Combination radiation and chemotherapy are commonly used to treat locoregionally advanced head and neck squamous cell carcinoma (HNSCC). Aggressive dosing of these therapies is significantly hampered by side effects due to normal tissue toxicity. Selenium represents an adjuvant that selectively sensitizes cancer cells to these treatments modalities, potentially by inducing lipid peroxidation (LPO). This study investigated whether one such selenium compound, methylseleninic acid (MSA), induces LP...
5 CitationsSource